Tigermed Announces Share Buyback Totaling 17.78 Million A-Shares as of June 16

Stock News06-16

An announcement from Tigermed (HKEX: 03347) reveals that as of June 16, 2026, the company has repurchased a total of 17.783 million of its own A-shares through a dedicated securities account for share buybacks, using the method of centralized competitive bidding.

The repurchased shares represent approximately 2.0654% of the company's current total share capital and about 2.4100% of its current total A-share capital.

The highest price paid per share was 39.96 yuan, while the lowest price was 38.22 yuan. The total transaction value amounted to 698.9 million yuan, excluding associated trading fees.

The execution of this buyback program is reported to be in full compliance with the company's approved share repurchase plan and the relevant legal and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment